RSS-Feed abonnieren
DOI: 10.1055/s-0029-1224181
© Georg Thieme Verlag KG Stuttgart · New York
Prolactin Suppresses Malonyl-CoA Concentration in Human Adipose Tissue
Publikationsverlauf
received 08.12.2008
accepted 06.05.2009
Publikationsdatum:
23. Juni 2009 (online)

Abstract
Prolactin is best known for its involvement in lactation, where it regulates mechanisms that supply nutrients for milk production. In individuals with pathological hyperprolactinemia, glucose and fat homeostasis have been reported to be negatively influenced. It is not previously known, however, whether prolactin regulates lipogenesis in human adipose tissue. The aim of this study was to investigate the effect of prolactin on lipogenesis in human adipose tissue in vitro. Prolactin decreased the concentration of malonyl-CoA, the product of the first committed step in lipogenesis, to 77±6% compared to control 100±5% (p=0.022) in cultured human adipose tissue. In addition, prolactin was found to decrease glucose transporter 4 (GLUT4) mRNA expression, which may cause decreased glucose uptake. In conclusion, we propose that prolactin decreases lipogenesis in human adipose tissue as a consequence of suppressed malonyl-CoA concentration in parallel with decreased GLUT-4 expression. In the lactating woman, this regulation in adipose tissue may enhance the provision of nutrients for the infant instead of nutrients being stored in adipose tissue. In hyperprolactinemic individuals, a suppressed lipogenesis could contribute to an insulin resistant state with consequences for the health.
Key words
lipogenesis - acetyl-CoA carboxylase - glucose transporter 4 - retinol binding protein 4 - human adipose tissue
References
- 1
Smith RW.
The effects of pregnancy, lactation and involution on the metabolism of glucose by
rat parametrial adipose tissue.
J Dairy Res.
1973;
40
353-360
MissingFormLabel
- 2
Romsos DR, Muiruri KL, Lin PY, Leveille GA.
Influence of dietary fat, fasting, and acute premature weaning on in vivo rates of
fatty acid synthesis in lactating mice.
Proc Soc Exp Biol Med.
1978;
159
308-312
MissingFormLabel
- 3
Vernon RG, Clegg RA, Flint DJ.
Metabolism of sheep adipose tissue during pregnancy and lactation. Adaptation and
regulation.
Biochem J.
1981;
200
307-314
MissingFormLabel
- 4
Barber MC, Travers MT, Finley E, Flint DJ, Vernon RG.
Growth-hormone-prolactin interactions in the regulation of mammary and adipose-tissue
acetyl-CoA carboxylase activity and gene expression in lactating rats.
Biochem J.
1992;
285
(( Pt 2))
469-475
MissingFormLabel
- 5
Barber MC, Clegg RA, Finley E, Vernon RG, Flint DJ.
The role of growth hormone, prolactin and insulin-like growth factors in the regulation
of rat mammary gland and adipose tissue metabolism during lactation.
J Endocrinol.
1992;
135
195-202
MissingFormLabel
- 6
Ling C, Hellgren G, Gebre-Medhin M, Dillner K, Wennbo H, Carlsson B, Billig H.
Prolactin (PRL) receptor gene expression in mouse adipose tissue: increases during
lactation and in PRL-transgenic mice.
Endocrinology.
2000;
141
3564-3572
MissingFormLabel
- 7
Ling C, Svensson L, Odén B, Weijdegård B, Edén B, Edén S, Billig H.
Identification of functional prolactin (PRL) receptor gene expression: PRL inhibits
lipoprotein lipase activity in human white adipose tissue.
J Clin Endocrinol Metab.
2003;
88
1804-1808
MissingFormLabel
- 8
Nilsson L, Binart N, Bohlooly YM, Bramnert M, Egecioglu E, Kindblom J, Kelly PA, Kopchick JJ, Ormandy CJ, Ling C, Billig H.
Prolactin and growth hormone regulate adiponectin secretion and receptor expression
in adipose tissue.
Biochem Biophys Res Commun.
2005;
331
1120-1126
MissingFormLabel
- 9
Herman MA, Kahn BB.
Glucose transport and sensing in the maintenance of glucose homeostasis and metabolic
harmony.
J Clin Invest.
2006;
116
1767-1775
MissingFormLabel
- 10
Ruderman NB, Saha AK, Kraegen EW.
Minireview: malonyl CoA, AMP-activated protein kinase, and adiposity.
Endocrinology.
2003;
144
5166-5171
MissingFormLabel
- 11
Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, Kotani K, Quadro L, Kahn BB.
Serum retinol binding protein 4 contributes to insulin resistance in obesity and type
2 diabetes.
Nature.
2005;
436
356-362
MissingFormLabel
- 12
Graham TE, Kahn BB.
Tissue-specific alterations of glucose transport and molecular mechanisms of intertissue
communication in obesity and type 2 diabetes.
Horm Metab Res.
2007;
39
717-721
MissingFormLabel
- 13
Roepstorff C, Halberg N, Hillig T, Saha AK, Ruderman NB, Wojtaszewski JF, Richter EA, Kiens B.
Malonyl-CoA and carnitine in regulation of fat oxidation in human skeletal muscle
during exercise.
Am J Physiol Endocrinol Metab.
2005;
288
E133-E142
MissingFormLabel
- 14
Zinder O, Hamosh M, Fleck TR, Scow RO.
Effect of prolactin on lipoprotein lipase in mammary glands and adipose tissue of
rats.
Am J Physiol.
1974;
226
742-748
MissingFormLabel
- 15
Landgraf R, Landraf-Leurs MM, Weissmann A, Hörl R, Werder von K, Scriba PC.
Prolactin: a diabetogenic hormone.
Diabetologia.
1977;
13
99-104
MissingFormLabel
- 16
Tourniaire J, Pallo D, Pousset G, Bizollon C, Bachelot I.
Diminished glucose tolerance and hyperinsulinism due to prolactin secreting adenoma.
Nouv Presse Med.
1974;
3
1705-1707
MissingFormLabel
- 17
Foss MC, Paula FJ, Paccola GM, Piccinato CE.
Peripheral glucose metabolism in human hyperprolactinaemia.
Clin Endocrinol (Oxf).
1995;
43
721-726
MissingFormLabel
- 18
Greenman Y, Tordjman K, Stern N.
Increased body weight associated with prolactin secreting pituitary adenomas: weight
loss with normalization of prolactin levels.
Clin Endocrinol (Oxf).
1998;
48
547-553
MissingFormLabel
- 19
Naliato EC, Violante AH, Caldas D, Lamounier Filho A, Loureiro CR, Fontes R, Schrank Y, Souza RG, Costa PL, Colao A.
Body fat in nonobese women with prolactinoma treated with dopamine agonists.
Clin Endocrinol (Oxf).
2007;
67
845-852
MissingFormLabel
- 20
Henderson DC, Doraiswamy PM.
Prolactin-related and metabolic adverse effects of atypical antipsychotic agents.
J Clin Psychiatry.
2008;
69
((Suppl 1))
32-44
MissingFormLabel
- 21
Baptista T, Zarate J, Joober R, Colasante C, Beaulieu S, Paez X, Hernandez L.
Drug induced weight gain, an impediment to successful pharmacotherapy: focus on antipsychotics.
Curr Drug Targets.
2004;
5
279-299
MissingFormLabel
- 22
Frayn KN, Tan GD, Karpe F.
Adipose tissue: a key target for diabetes pathophysiology and treatment?.
Horm Metab Res.
2007;
39
739-742
MissingFormLabel
- 23
Flint DJ, Clegg RA, Vernon RG.
Prolactin and the regulation of adipose-tissue metabolism during lactation in rats.
Mol Cell Endocrinol.
1981;
22
265-275
MissingFormLabel
- 24
Forsyth IA, Wallis M.
Growth hormone and prolactin – molecular and functional evolution.
J Mammary Gland Biol Neoplasia.
2002;
7
291-312
MissingFormLabel
- 25
Ng TB.
Studies on hormonal regulation of lipolysis and lipogenesis in fat cells of various
mammalian species.
Comp Biochem Physiol B.
1990;
97
441-446
MissingFormLabel
- 26
Rosenbaum M, Gertner JM, Leibel RL.
Effects of systemic growth hormone (GH) administration on regional adipose tissue
distribution and metabolism in GH-deficient children.
J Clin Endocrinol Metab.
1989;
69
1274-1281
MissingFormLabel
- 27
Ryan EA, Enns L.
Role of gestational hormones in the induction of insulin resistance.
J Clin Endocrinol Metab.
1988;
67
341-347
MissingFormLabel
- 28
Jarrett JCN, Ballejo G, Saleem TH, Tsibris JC, Spellacy WN.
The effect of prolactin and relaxin on insulin binding by adipocytes from pregnant
women.
Am J Obstet Gynecol.
1984;
149
250-255
MissingFormLabel
- 29
Asai-Sato M, Okamoto M, Endo M, Yoshida H, Murase M, Ikeda M, Sakakibara H, Takahashi T, Hirahara F.
Hypoadiponectinemia in lean lactating women: Prolactin inhibits adiponectin secretion
from human adipocytes.
Endocr J.
2006;
53
555-562
MissingFormLabel
Correspondence
L. A. Nilsson
Institute of Neuroscience and Physiology
Sahlgrenska Academy at University of Gothenburg
P. O. Box 434
405 30 Göteborg
Sweden
Telefon: +46/31/786 3533
Fax: +46/31/786 3512
eMail: louise.nilsson@gu.se